Theyre often driven by the belief that pain is bad and rest is good, while also using a reduction in pain as the primary metric for success
they are essential for maintaining the products quality and, by extension, the validity of research
Most formulations available commercially are marketed as research compounds, and regulatory agencies have expressed concerns about the safety and quality control of unregulated peptide products
The approach adds complexity but extends useful product life for users with lower consumption rates
Overgrowth of bacteria: Some people develop vitamin B 12 deficiency as a result of conditions that slow the movement of food through the intestines (diabetes, scleroderma, strictures, diverticula), allowing intestinal bacteria to multiply and overgrow in the upper part of the small intestine
Injectable or compounded GHK-Cu formulations may be offered in specialized clinics, but these fall under off-label or research-use categories
